LoQus23 Nominates LQT-23 as First-in-Class Huntington’s Candidate
06 Jan 2026 //
PR NEWSWIRE
LoQus23 Raises 35M For Huntington`s Disease Therapy
02 Oct 2024 //
PR NEWSWIRE
LoQus23 appoints Dr. Melanie Ivarsson, OBE, as Non-Executive Director
24 Jan 2022 //
PRNEWSWIRE

Market Place
Sourcing Support